| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |